Top Story

Repeat revisions for ICDs, CRT-Ds linked to substantial costs

Repeat revisions for ICDs, CRT-Ds linked to substantial costs
May 22, 2015

When a patient with an implantable cardioverter defibrillator or a cardiac resynchronization therapy defibrillator undergoes more than one revision procedure, substantial costs are incurred, researchers reported in Circulation: Cardiovascular Quality and Outcomes.

Researchers sought to explore patterns of revisions and complications associated with ICD and CRT-D devices and to quantify and estimate the related costs.

Meeting News Coverage

High-intensity statin use low in patients with diabetes, high CVD risk

May 22, 2015
NASHVILLE, Tenn. - Patients with type 2 diabetes at very high risk for cardiovascular disease are often not taking high-intensity statins, further increasing their risk…
Vivek Y. Reddy, MD Meeting News CoveragePerspective

SELECT-LV: Wireless LV endocardial pacing may benefit CRT nonresponders

May 22, 2015
BOSTON — A wireless left ventricular endocardial pacing system could be a viable alternative for patients with HF in whom cardiac resynchronization therapy is not…
Khaled Awad, MD Meeting News CoveragePerspective

ProMRI: ICD safe in patients undergoing cardiac, thoracic spine MRI

May 21, 2015
BOSTON — An implantable cardioverter defibrillator was safe and effective in patients undergoing a cardiac or thoracic spine MRI at 1.5 T, according to the results…
Takaaki Kakihana, PT, MSc Meeting News Coverage

Hip flexor muscle exercise may mitigate walking pain in patients with PAD

May 21, 2015
Exercise training for the hip flexor muscle could mitigate calf pain while walking and increase walking distance among patients with peripheral arterial disease…
More News Headlines »
CME
Best of Lipid Forum III

Best of Lipid Forum III

This activity is supported by an educational grant from Amgen, Inc.

Appropriate therapies for various dyslipidemias remain a challenge for practitioners struggling to reduce residual risk…
More »
Meeting News Coverage Video
VIDEO: Community awaits PCSK9 inhibitor phase 3 results, approval

VIDEO: Community awaits PCSK9 inhibitor phase 3 results, approval

May 17, 2015
SAN DIEGO — C. Noel Bairey Merz, MD, FACC, director of the Barbra Streisand Women’s Heart Center in the…
More »
CME
Cardiology Case Consults

The Patient With Statin Intolerance

No commercial support for this activity.

This CME activity will focus on the diagnosis and management of patients with statin intolerance.
More »
morganatic-roan